$1.59
-0.01[-0.63%]
At close: Apr 26
$1.59
0[0.00%]
After Hours: 4:00PM EDT
CytomX Therapeutics
(NASDAQ:CTMX)CytomX Therapeutics Stock (NASDAQ:CTMX), Insider Trading Activity
CytomX Therapeutics: Insider buying and selling updated today.
Insider Shares Owned
1.668M
Insider Percentage Owned
2.46%
Institutional Shares Held
9.170M
Institutional Percentage Held
13.5%
Filing Date | Insider Names | Insider Title | Qty. | Price | Size ($) | Type | Δ Own | Own | Trade Dates | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 21, 2024 | Lloyd Rowland | GENERAL COUNSEL | -5.268K | $2.09 | -$10.99K | SELL | -4.28% | 117.728K | Mar 19 | View |
| Mar 21, 2024 | Sean A McCarthy | CEO | -20.223K | $2.09 | -$42.18K | SELL | -3.17% | 617.639K | Mar 19 | View |
| Mar 21, 2024 | Christopher Ogden | SVP, FINANCE AND ACCOUNTING | -2.971K | $2.09 | -$6.20K | SELL | -3.35% | 85.686K | Mar 19 | View |
| Mar 21, 2024 | Marcia Belvin | SVP, CHIEF SCIENTIFIC OFFICER | -12.795K | $2.09 | -$26.68K | SELL | -7.05% | 168.579K | Mar 19 | View |
| Mar 21, 2024 | Jeffrey B Landau | CHIEF BUSINESS OFFICER | -6.562K | $2.09 | -$13.69K | SELL | -5.48% | 113.24K | Mar 19 | View |
| Dec 22, 2023 | Sean A McCarthy | CEO | -13.551K | $1.38 | -$18.71K | SELL | -2.41% | 547.862K | Dec 20 | View |
| Dec 22, 2023 | Marcia Belvin | SVP, CHIEF SCIENTIFIC OFFICER | -4.077K | $1.38 | -$5.63K | SELL | -2.56% | 155.124K | Dec 20 | View |
| Dec 22, 2023 | Jeffrey B Landau | CHIEF BUSINESS OFFICER | -4.077K | $1.38 | -$5.63K | SELL | -4.34% | 89.802K | Dec 20 | View |
| Dec 22, 2023 | Lloyd Rowland | GENERAL COUNSEL | -4.077K | $1.38 | -$5.63K | SELL | -3.99% | 97.996K | Dec 20 | View |
| Dec 22, 2023 | Christopher Ogden | SVP, FINANCE AND ACCOUNTING | -1.99K | $1.38 | -$2.75K | SELL | -3.93% | 48.657K | Dec 20 | View |
| Sep 22, 2023 | Marcia Belvin | SVP, CHIEF SCIENTIFIC OFFICER | 7.131K | $1.30 | -$5.36K | GRANT | 5.06% | 147.951K | Sep 20 - Sep 22 | View |
| Sep 22, 2023 | Jeffrey B Landau | CHIEF BUSINESS OFFICER | 7.131K | $1.30 | -$5.36K | GRANT | 9.85% | 79.559K | Sep 20 - Sep 22 | View |
| Sep 22, 2023 | Sean A McCarthy | CEO | 25.399K | $1.30 | -$18.99K | GRANT | 5.09% | 523.913K | Sep 20 - Sep 22 | View |
| Sep 22, 2023 | Lloyd Rowland | GENERAL COUNSEL | 9.514K | $1.30 | -$7.14K | GRANT | 13.38% | 80.609K | Sep 20 - Sep 22 | View |
| Mar 31, 2023 | Elaine V Jones | 5K | $1.55 | $7.75K | BUY | 3521.13% | 5.142K | Mar 29 | View | |
| Mar 20, 2023 | Christopher Ogden | SVP, FINANCE AND ACCOUNTING | -516 | $1.98 | -$1.02K | SELL | -1.35% | 37.772K | Mar 16 | View |
| Mar 20, 2023 | Carlos Campoy | CHIEF FINANCIAL OFFICER | -1.748K | $1.98 | -$3.46K | SELL | -4.37% | 38.224K | Mar 16 | View |
| Mar 20, 2023 | Sean A McCarthy | CEO | -7.121K | $1.88 | -$13.39K | SELL | -1.46% | 481.979K | Mar 16 | View |
| Mar 20, 2023 | Lloyd Rowland | GENERAL COUNSEL | -2.037K | $1.98 | -$4.03K | SELL | -2.79% | 71.095K | Mar 16 | View |
FAQ
Is Insider trading legal?
Insider trading is legal so long as the insiders report those trades to the SEC. Illegal securities trading occurs when the insider is violating a fiduciary duty or fails to report their trades.
What are some examples of market manipulation?
Insider trading, pump and dump schemes, front running and wash trades are all examples of market manipulation. Investors who track insider asset movement should think carefully about why these insiders are trading their stocks before moving forward.
Browse insider trades on all stocks.